Please join us at the Ray Allen Golf Classic and Ray of Hope Luncheon hosted by Shannon and Ray Allen and Andria and Javier Holtz. Ray and Shannon’s son Walker, 6, was diagnosed with type 1 diabetes (T1D) at 17 months old. Andrew Holtz, 19, was diagnosed just after his seventh birthday. The Allen and […]
Michelle Crouse, of the JDRF Alabama Chapter, has been a caring volunteer, a dedicated advocate, and, quite literally, the calm in a storm. Now her 13-year-old son Cameron, diagnosed with type 1 diabetes at age two, is taking up the family tradition with his own volunteer and advocacy work.
Although scientists are still working to determine what causes type 1 diabetes (T1D), research has given us insights into the disease process – knowledge that may eventually lead to potential therapies. One idea that has been explored over the past several years is that of beta cell stress and its connection to T1D, and a […]
We’re the plan to change the future type. JDRF research focuses on key therapies that hold significant promise in turning Type One into Type None, including: artificial pancreas, encapsulation, smart insulin, restoration, and prevention.
Linda Wright has been a teacher, a salesperson and manager in a marketing company, and now a chef and the owner of her own catering business. She says, “Volunteering with JDRF incorporates all those professions.”
Last year JDRF took a number of significant actions to broaden the resources available in the T1D research and development space – three of them are highlighted here. Each of these will help speed progress towards our research goals across our portfolio of research objectives to develop and deliver novel T1D therapies to patients. In […]
The holidays are upon us! No matter which celebration(s) you observe—Thanksgiving, Hanukkah, Christmas, Kwanzaa, New Year’s Eve, you name it—we’ve got a wealth of information from our archives to help you ring in your healthiest, happiest type 1 diabetes (T1D) holiday season yet.
A new JDRF-funded study will evaluate whether metformin—a drug commonly used to treat type 2 diabetes (T2D)—combined with standard insulin therapy could safely improve blood-glucose control in overweight children and adolescents with type 1 diabetes (T1D). For more than 50 years, metformin has proven safe and effective in helping to control blood-glucose levels in people […]
A clinical study published in PNAS provides further proof-of-concept that beta cell encapsulation holds real promise for making islet implantation a viable therapy for people with type 1 diabetes (T1D).
Type 1 diabetes (T1D) scientists have believed for some time that communities of bacterial microorganisms in the gut, which make up the microbiome, are in some way related to immune system defects and the autoimmune response that leads to T1D. Previous research has hypothesized that the diversity or abundance of specific bacteria within the microbiome […]